@article{75a2c2a3d8c44ab1979e38c75daadb14,
title = "Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia",
author = "Driessen, \{Emma M.C.\} and Pinhan{\c c}os, \{Sandra S.Mimoso\} and Pauline Schneider and \{De Lorenzo\}, Paola and Valsecchi, \{Maria G.\} and Rob Pieters and Stam, \{Ronald W.\}",
note = "Funding Information: The authors thank the members and participating institutes of the INTERFANT-99 study for generously providing leukaemic samples. Members of the INTERFANT-99 study are as follows: M. Campbell (Programa Infantil Nacional de Drogas Atineoplasicas [PINDA]), M. Felice (Argentina), A. Ferster (Children's Leukaemia Group [CLCG]), I. Hann and A. Vora (UK Children's Cancer Study Group [UKCCSG]), L. Hovi (Nordic Society of Paediatric Haematology and Oncology [NOPHO]), G. Janka-Schaub (Cooperative Study Group for Treatment of ALL [COALL]), C.K. Li (Hong Kong), G. Mann (Berlin-Frankfurt-Munster Group-Austria [BFM-A]), T. LeBlanc (French ALL Group [FRALLE]), R. Pieters (Dutch Childhood Oncology Group [DCOG]), G. de Rossi and A. Biondi (Associazione Italiana Ematologia Oncologia Pediatrica [AIEOP]), J. Rubnitz (St Jude Children's Research Hospital [SJCRH]), M. Schrappe (Berlin–Frankfurt–Munster Group Germany [BFM-G]), L. Silverman (Dana-Farber Cancer Institute [DFCI]), J. Stary (Czech Paediatric Haematology [CPH]), R. Suppiah (Australian and New Zealand Children's Haematology/Oncology Group [ANZCHOG]), T. Szczepanski (Polish Paediatric Leukaemia and Lymphoma Study Group [PPLLSG]), and M. Valsecchi and P. de Lorenzo (Trial Operating Center [CORS]). Research support: this study was financially supported by research funding from KIKA (Kinderen Kankervrij) . Furthermore, RWS was financially supported by the Dutch Cancer Society (KWF Kankerbestrijding) .",
year = "2016",
month = apr,
day = "1",
doi = "10.1016/j.ejca.2015.12.031",
language = "English",
volume = "57",
pages = "87--90",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd.",
}